Pancreatic Cancer Research

ResearcherAffiliated Hospital of Qingdao UniversityActive in the last 2 years

Zimin Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3104-4287; OpenAlex author ID A5027702597. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Targeting myeloid cells in pancreatic ductal adenocarcinoma: from primary tumors to liver metastasis. Co-author DOI 10.3389/fimmu.2025.1555036↗
  2. Propofol inhibits growth and invasion of pancreatic cancer cells through regulation of the miR-21/Slug signaling pathway. Co-author PMID 27829997↗
  3. pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression. Co-author DOI 10.1186/s12957-015-0451-7↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qian Yu · 1 shared paper, 2025 · strength 0.30
  2. Huan Zhang · 1 shared paper, 2025 · strength 0.30
  3. Ruining Gong · 1 shared paper, 2025 · strength 0.30
  4. David Kuang-Fu Chang · 1 shared paper, 2025 · strength 0.30
  5. Meiqin Yu · 1 shared paper, 2016 · strength 0.07
  6. Dong Chen · 1 shared paper, 2015 · strength 0.06
  7. Min Wang · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.